Immediate Impact
5 by Nobel laureates 8 from Science/Nature 75 standout
Citing Papers
Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
2022 Standout
Works of Elizabeth Ness being referenced
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.
1998
Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Elizabeth Ness | 350 | 90 | 86 | 331 | 257 | 17 | 757 | |
| Jennifer Tseng | 326 | 80 | 77 | 324 | 155 | 23 | 782 | |
| D C Talbot | 338 | 26 | 47 | 381 | 276 | 26 | 740 | |
| Rita Azevedo | 511 | 36 | 141 | 172 | 103 | 37 | 983 | |
| Robert L. DeWitty | 263 | 50 | 133 | 450 | 361 | 36 | 961 | |
| Teresita Muñoz-Antonia | 626 | 51 | 69 | 366 | 160 | 49 | 980 | |
| Amanda Croft | 555 | 62 | 55 | 205 | 119 | 33 | 874 | |
| John D. Sprandio | 258 | 94 | 205 | 365 | 231 | 27 | 964 | |
| Brett Ewald | 448 | 28 | 47 | 328 | 121 | 19 | 886 | |
| Praveen Vikas | 251 | 70 | 105 | 528 | 151 | 27 | 935 | |
| Leah Rider | 351 | 29 | 79 | 367 | 391 | 11 | 865 |
All Works
Login with ORCID to disown or claim papers
Loading papers...